SLAMF7 and Miyoshi myopathy: indicated that CS-1 CAR-NK92 cells displayed CS1-dependent recognition and killing capacity for both MM cell lines and primary MM cells; this cell therapy prolonged survival in xenograft model mice by inhibiting the growth of MM cells (85).